These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 15266902)

  • 1. Vasopressin mediates neuroprotection in mice by stimulation of V1 vasopressin receptors: influence of PI-3 kinase and gap junction inhibitors.
    Tyagi MG; Parthiban KV
    Indian J Exp Biol; 2003 Jun; 41(6):574-80. PubMed ID: 15266902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia.
    Vakili A; Kataoka H; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):1012-9. PubMed ID: 15744246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of arginine vasopressin receptors and angiotensin receptor subtypes on the water intake and arterial blood pressure induced by vasopressin injected into the lateral septal area of the rat.
    Abrão Saad W; Antonio De Arruda Camargo L; Sérgio Cerri P; Simões S; Abrão Saad W; Garcia G; Izabel Gutierrez L; Guarda I; Saad Guarda R
    Auton Neurosci; 2004 Mar; 111(1):66-70. PubMed ID: 15109940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
    Reymond-Marron I; Tribollet E; Raggenbass M
    Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice.
    Fujiwara Y; Hiroyama M; Sanbe A; Yamauchi J; Tsujimoto G; Tanoue A
    J Endocrinol; 2007 Feb; 192(2):361-9. PubMed ID: 17283236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic effect of arginine vasopressin on adult rat cardiac fibroblast: involvement of PKC-erk1/2 pathway.
    Yan-ping H; Lian-you Z; Qiang-sun Z; Shao-wei L; Xiao-yan Z; Xiao-long L; Xiao-lin N; Xia L
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):72-81. PubMed ID: 18645411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Through V2, not V1 receptor relating to endogenous opiate peptides, arginine vasopressin in periaqueductal gray regulates antinociception in the rat.
    Yang J; Chen JM; Liu WY; Song CY; Lin BC
    Regul Pept; 2006 Dec; 137(3):156-61. PubMed ID: 17011056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
    Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
    J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
    Tyagi MG; Shanthi M; Keshavan V; Vikram GS
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):257-62. PubMed ID: 15319803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nitric oxide and protein kinase C in the tachyphylaxis to vasopressin in rat aortic rings.
    Hamel C; Millette E; Lamontagne D
    Life Sci; 2005 Jul; 77(10):1069-81. PubMed ID: 15978263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.
    Pena A; Murat B; Trueba M; Ventura MA; Wo NC; Szeto HH; Cheng LL; Stoev S; Guillon G; Manning M
    J Med Chem; 2007 Feb; 50(4):835-47. PubMed ID: 17300166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents.
    Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G
    Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
    Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
    Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin and angiotensin receptors of the medial septal area of the brain in the control of thirst and salt appetite induced by vasopressin in water-deprived and sodium-depleted rats.
    Maria Pavan de Arruda Camargo G; Antônio de Arruda Camargo L; Saad WA
    Pharmacol Biochem Behav; 2007 Oct; 87(4):393-9. PubMed ID: 17573101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.
    Destot-Wong KD; Liang K; Gupta SK; Favrais G; Schwendimann L; Pansiot J; Baud O; Spedding M; Lelièvre V; Mani S; Gressens P
    Neuropharmacology; 2009 Sep; 57(3):277-86. PubMed ID: 19501111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of neuroprotection by donepezil pretreatment in rat cortical neurons chronically treated with donepezil.
    Takada-Takatori Y; Kume T; Ohgi Y; Izumi Y; Niidome T; Fujii T; Sugimoto H; Akaike A
    J Neurosci Res; 2008 Dec; 86(16):3575-83. PubMed ID: 18655200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of centrally administered vasopressin on orofacial pain perception in rats.
    Zubrzycka M; Janecka A
    Brain Res; 2005 Jul; 1051(1-2):112-6. PubMed ID: 15993385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17beta-estradiol reduces the effect of metabolic inhibition on gap junction intercellular communication in rat cardiomyocytes via the estrogen receptor.
    Chung TH; Wang SM; Wu JC
    J Mol Cell Cardiol; 2004 Nov; 37(5):1013-22. PubMed ID: 15522278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.